lcz696
Showing 1 - 25 of 30
Heart Failure With Preserved Ejection Fraction (HFpEF) Trial in Japan (LCZ696)
Terminated
- Heart Failure With Preserved Ejection Fraction (HFpEF)
- LCZ696
-
Seto-city, Aichi, Japan
- +16 more
Oct 7, 2021
Chronic Heart Failure With Reduced Ejection Fraction Trial in Germany (LCZ696, Enalapril, Placebo matching enalapril)
Completed
- Chronic Heart Failure With Reduced Ejection Fraction
- LCZ696
- +3 more
-
Regensburg, Bavaria, Germany
- +33 more
Oct 7, 2021
Heart Failure Trial in Moscow (LCZ696)
Completed
- Heart Failure
- LCZ696
-
Moscow, Russian FederationGOUVPO Russian PeoplesĀ“ Friendship University, Center of Applied
Dec 16, 2020
Heart Failure With Reduced Ejection Fraction Trial in Worldwide (LCZ696)
Completed
- Heart Failure With Reduced Ejection Fraction
- LCZ696
-
Quilmes, Buenos Aires, Argentina
- +152 more
Mar 29, 2021
Heart Failure With Reduced Ejection Fraction (HF-rEF) Trial in Worldwide (LCZ696)
No longer available
- Heart Failure With Reduced Ejection Fraction (HF-rEF)
- LCZ696
-
Vero Beach, Florida
- +288 more
Feb 10, 2021
Heart Failure With Preserved Ejection Fraction Trial in Worldwide (LCZ696, Valsartan)
Completed
- Heart Failure With Preserved Ejection Fraction
- LCZ696
- Valsartan
-
Huntsville, Alabama
- +716 more
Sep 8, 2020
Mitral Valve Insufficiency, Left Ventricular Dysfunction Trial in Incheon, Seoul (LCZ696, Valsartan)
Completed
- Mitral Valve Insufficiency
- Left Ventricular Dysfunction
- LCZ696
- Valsartan
-
Incheon, Korea, Republic of
- +3 more
Jan 8, 2018
Chronic Heart Failure With Reduced Ejection Fraction Trial in Worldwide (LCZ696)
Completed
- Chronic Heart Failure With Reduced Ejection Fraction
- LCZ696
-
Huntsville, Alabama
- +396 more
Feb 19, 2019
Essential Hypertension Trial in Worldwide (LCZ696, Olmesartan, Placebo of LCZ696)
Completed
- Essential Hypertension
- LCZ696
- +3 more
-
Beijing, Beijing, China
- +49 more
Nov 8, 2016
Hypertension Trial in Moscow (LCZ696, Valsartan)
Completed
- Hypertension
- LCZ696
- Valsartan
-
Moscow, Russian FederationNovartis Investigative Site
Oct 20, 2015
Mild to Moderate Hypertension Trial in Berlin (LCZ696, Sildenafil)
Completed
- Mild to Moderate Hypertension
- LCZ696
- Sildenafil
-
Berlin, GermanyNovartis Investigative Site
Oct 6, 2015
Salt-sensitive Hypertension Trial in Worldwide (Valsartan, LCZ696)
Hepatic Impairment Trial in Grunstadt (LCZ696)
Completed
- Hepatic Impairment
- LCZ696
-
Grunstadt, GermanyNovartis Investigative Site
Jul 11, 2015
Hypertension, Concurrent Obesity Trial in Hannover, Neuss, Maastricht (LCZ696, amlodipine, Placebo)
Completed
- Hypertension
- Concurrent Obesity
- LCZ696
- +2 more
-
Hannover, Germany
- +2 more
Jul 11, 2015
Essential Hypertension Trial in Worldwide (LCZ696, Amlodipine, Placebo)
Completed
- Essential Hypertension
- LCZ696
- +2 more
-
Shijiazhuang, Hebei, China
- +27 more
Oct 1, 2015
Essential Hypertension Trial in Worldwide (LCZ696, Amlodipine, Hydrochlorothiazide (HCTZ))
Completed
- Essential Hypertension
- LCZ696
- +2 more
-
Chongqing, Chongqing, China
- +32 more
Sep 22, 2015
Hypertension With Renal Dysfunction Trial in Japan (LCZ696)
Completed
- Hypertension With Renal Dysfunction
- LCZ696
-
Sapporo-city, Hokkaido, Japan
- +12 more
Aug 7, 2015
Essential Hypertension Trial in Japan (LCZ696, Olmesartan, Placebo)
Completed
- Essential Hypertension
- LCZ696
- +2 more
-
Kamogawa-City, Chiba, Japan
- +60 more
Sep 25, 2015
Essential Hypertension Trial in Worldwide (Olmesartan, Placebo, LCZ696)
Completed
- Essential Hypertension
- Olmesartan
- +2 more
-
Chongqing, Chongqing, China
- +77 more
Oct 1, 2015